An internally controlled peripheral biomarker for Alzheimer’s disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin
Author of publication
Tapan K. Khan and Daniel L. Alkon
Date of publication
29/08/2006
Download
RW-Admin
Association of Cognitive Function Trajectories in Centenarians With Postmortem Neuropathology, Physical Health, and Other Risk Factors for Cognitive Decline
Prev post
PKC Deficits in Alzheimer’s Disease Brains and Skin Fibroblasts
Next post
Search for:
Recent Posts
Spotlighting Accurate, Early Diagnosis of Alzheimer’s Disease: World Alzheimer’s Month
SYNAPS Dx Opens High-Tech Laboratory Supporting Research & Commercialization of DISCERN, Highly Accurate, Minimally Invasive Alzheimer’s Disease Diagnostic Test
A Breakthrough in Diagnosing Alzheimer’s Disease
SYNAPS Dx Releases Autopsy-Confirmed Results for DISCERN Alzheimer’s Test MI Biomarker, Accurately Diagnoses Alzheimer’s in Presence of Other Co-Morbid Pathologies
SYNAPS Dx Showcases Autopsy-Confirmed Results for DISCERN Alzheimer’s Test MI Biomarker, For Identifying Alzheimer’s in Presence of Other Co-Morbid Pathologies
Recent Comments
Archives
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
October 2019
September 2019
December 2018
November 2018
Categories
Uncategorized
Meta
Log in
Entries feed
Comments feed
WordPress.org
Input your search keywords and press Enter.
Recent Comments